Lymphoma Newswire (Page 7)

Lymphoma Newswire (Page 7)

Comprehensive Real-Time News Feed for Lymphoma. (Page 7)

Results 121 - 140 of 61,952 in Lymphoma

  1. Lymphoma Research Foundation to Host Annual Gala at New York's...Read the original story

    Friday Sep 15 | PRWeb

    Held for the second year in a row during Blood Cancer Awareness Month , LRF will host its 2017 Annual Gala at the historic Plaza Hotel in its famed Grand Ballroom. LRF's Annual Gala brings together hundreds of leaders from across the lymphoma community, including members of LRF's Scientific Advisory Board, Board of Directors, corporate partners, clinicians, researchers, healthcare providers, patients, survivors, and volunteers to raise essential funds to support LRF's critical mission of eradicating lymphoma and serving those impacted by this blood cancer.

    Comment?

  2. Financial Comparison: Soligenix (SNGX) vs. Its RivalsRead the original story w/Photo

    Friday Sep 15 | AmericanBankingNews.com

    ... utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL), formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) ...

    Comment?

  3. 'Toxic' tattoo ink particles can travel to your lymph nodes: studyRead the original story w/Photo

    Friday Sep 15 | GlobalNews

    ... doing its job in trying to protect the human organism." Dr. Matthew Cheung, a hematologist who works primarily with lymphoma patients, concurred with Kellett, adding that the study sheds new light on the type, concentration and size of the particles ...

    Comment?

  4. Comparing Portola PharmaceuticalsRead the original story w/Photo

    Friday Sep 15 | IntersportsWire

    ... has six approved oncology/hematology products that target different types of cancer, including non-Hodgkin's lymphoma (NHL), advanced metastatic colorectal cancer (mCRC), acute lymphoblastic leukemia (ALL) and multiple myeloma (MM). It also has ...

    Comment?

  5. Leukemia Race Team Marks 10 Years Running For Verona ResidentRead the original story w/Photo

    Friday Sep 15 | My Verona NJ

    The Leukemia & Lymphoma Society's New Jersey chapter has officially kicked off their 2017/2018 fundraising campaign for the NJ Marathon event weekend, and local participating team, Caldwell TEAM R4C are aiming to reach even higher this year with Team In Training's lineup of innovative, high-caliber events in running, cycling and triathlon offerings, with expert coaches who bring dedication and commitment to the program. TNT is helping LLS's goal to find cures for blood cancers and ensure that patients have access to lifesaving treatments by expanding ways for participants to turn training into treatment.

    Comment?

  6. Distraught mum refused to leave A&E until doctors diagnosed her son's mystery symptomsRead the original story w/Photo

    Friday Sep 15 | Chronicle Live

    ... night when his lips started to turn blue. But nothing could have prepared her for the news that he had Hodgkins Lymphoma - a type of cancer which had left him with tumours in his chest and stomach. "At the time I just kept thinking they had made a ...

    Comment?

  7. Avera Medical Minute AMcK: Advancing medical care through clinical trialsRead the original story w/Photo

    Thursday Sep 14 | KSFY

    "This is my second go around. Fall of 2002, it was Non-Hodgkin large B-cell Lymphoma.

    Comment?

  8. Seattle Genetics: Good Time To Buy Based On Adcetris Label ExpansionRead the original story w/Photo

    Friday Sep 15 | Seeking Alpha

    Seattle Genetics is a midsized company with outsized dreams. Those dreams, thus far, were mostly centered around revenues it made from its one big - Adcetris - in one small market, 2nd line classical Hodgkins lymphoma, and in another even smaller market, 2nd line Systemic anaplastic large cell lymphoma , a very rare type of non-Hodgkin lymphoma.

    Comment?

  9. Epizyme Striding Into Epigenetic BreakthroughsRead the original story w/Photo

    Friday Sep 15 | Seeking Alpha

    ... Eisai ( OTCPK:ESALY ) for treatment of hematological malignancies (large B cell lymphomas (DLBCL) and follicular lymphoma (FL)) and genetically defined solid tumors. Its second candidate pinometostat, a DOT1L inhibitor being developed with Celgene ( ...

    Comment?

  10. Rhys Powell's parents want his funeral to be a special day remembering his lifeRead the original story w/Photo

    Friday Sep 15 | Western Gazette

    ... ter overcoming leukaemia through a bone marrow transplant he helped raised money for charities, such as Leukaemia & Lymphoma Research, on sponsored bike rides as a child.

    Comment?

  11. Bayer cancer drug gets FDA approval to treat lymphomaRead the original story w/Photo

    Friday Sep 15 | USA Today

    Pharmaceutical giant Bayer won swift U.S. regulatory approval to sell a drug that could help treat up to 30% of lymphoma patients. Bayer cancer drug gets FDA approval to treat lymphoma Pharmaceutical giant Bayer won swift U.S. regulatory approval to sell a drug that could help treat up to 30% of lymphoma patients.

    Comment?

  12. Jet lag drug may aid cancer patientsRead the original story w/Photo

    Friday Sep 15 | PhysOrg Weblog

    ... of melatonin, a hormone made by a small gland in the brain, for treating blood cancers such as leukemia and lymphoma. They point to evidence that melatonin boosts the immune ... Oral melatonin can protect the small intestine in rats subjected to ...

    Comment?

  13. 3 Reasons Why Gilead Sciences Stock Is a Buy NowRead the original story w/Photo

    Friday Sep 15 | The Motley Fool

    ... In trials, CAR-T has produced impressive response rates in tough-to-treat patients diagnosed with non-Hodgkin lymphoma. The Food and Drug Administration (FDA) is supposed to make an approval decision on Kite Pharma's lead CAR-T, axi-cel, on November ...

    Comment?

  14. Sigma Alpha Iota presents: "Music for Patients" benefit concertRead the original story w/Photo

    Friday Sep 15 | The Lantern

    Music service organization Sigma Alpha Iota will present its second annual benefit concert Sunday to raise money for patients affected by Non-Hodgkin's Lymphoma. Music service organization Sigma Alpha Iota will present its second annual benefit concert Sunday to raise money for patients at the Wexner Medical Center James Comprehensive Cancer Center affected by Non-Hodgkin's Lymphoma.

    Comment?

  15. Be the light for families dealing with blood cancerRead the original story w/Photo

    Friday Sep 15 | Manning River Times

    ... setting off on a picturesque lantern walk. "Everyday 35 people are diagnosed with a blood cancer such as leukaemia, lymphoma, myeloma or a related blood disorders and they'll turn to the Leukaemia Foundation for help," Leukaemia Foundation community ...

    Comment?

  16. Western Mail letters: Friday, September 15, 2017Read the original story w/Photo

    Friday Sep 15 | IcNetwork

    ... icle reversing!" warning have to be followed by the same alert in Welsh? Every 28 minutes someone is diagnosed with lymphoma. It is the UK's fifth most common cancer, and the most common form of blood cancer, yet

    Comment?

  17. Kansas City Attorney Raises Funds for People with Blood CancersRead the original story w/Photo

    Friday Sep 15 | PRWeb

    Kansas City family law attorney Nathalie C. Elliott, of the Levy Craig Law Firm, will participate in the Light The Night Walk for the Leukemia & Lymphoma Society. Nathalie C. Elliott , a family law attorney at the Levy Craig Law Firm in Kansas City, MO, was diagnosed with leukemia on November 10, 2010.

    Comment?

  18. CTI BioPharma Corp. (CTIC) Expected to Post Q3 2017 Earnings of ($0.32) Per ShareRead the original story w/Photo

    Friday Sep 15 | The Breeze

    ... in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). Receive News & Ratings for CTI BioPharma Corp. Daily - Enter your email address below to receive a concise daily summary of ...

    Comment?

  19. Global Anatomy Pathology Market is poised to reach USD 21.78 billion by 2021Read the original story

    Friday Sep 15 | Emailwire.com

    Anatomy Pathology Market by products (instruments and accessories), by application (lymphoma, breast, lung, colorectal, cervical and prostate), by end-user (diagnostic lab, hospitals, and physicians' office lab), and by Region ( EMAILWIRE.COM , ...

    Comment?

  20. German stocks - Factors to watch on September 15Read the original story w/Photo

    Thursday Sep 14 | Reuters

    ... U.S. Food and Drug Administration said on Thursday it has approved the chemicals group's treatment for follicular lymphoma, a cancer of the lymph system. Some 5,300 parcel delivery jobs in Germany are unfilled, indicating a possible bottleneck for ...

    Comment?